Interact to see
Advertisement
Advertisement
MEDCX vs REBAX
MEDCX vs REBAX Comparison
Open Charts MEDCX vs REBAX
MFS Emerging Markets Debt C
Price$12.57
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets7.55B
Columbia Emerging Markets Bond A
Price$9.98
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets341.82M
MEDCX vs REBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
MEDCX vs. REBAX commentary
Oct 07, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEDCX is a Hold and REBAX is a Hold.
FUNDAMENTALS
Fundamentals
MEDCX has more cash in the bank: 7.55B vs. REBAX (342M). REBAX pays higher dividends than MEDCX: REBAX (4.91) vs MEDCX (4.53). MEDCX was incepted earlier than REBAX: MEDCX (23 years) vs REBAX (20 years). MEDCX (1.82) is less costly to investors than REBAX (1.13). MEDCX is a more actively managed with annual turnover of: 58.00 vs. REBAX (41.00). MEDCX has a lower initial minimum investment than REBAX: MEDCX (1000) vs REBAX (2000). REBAX annual gain was more profitable for investors over the last year : 7.90 vs. MEDCX (6.74). REBAX return over 5 years is better than : 11.08 vs. MEDCX (8.21).
| MEDCX | REBAX | MEDCX / REBAX | |
| Total Expense Ratio | 1.81 | 1.13 | 160% |
| Annual Report Gross Expense Ratio | 1.82 | 1.13 | 161% |
| Fund Existence | 23 years | 20 years | - |
| Gain YTD | 8.372 | 9.571 | 87% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 1000 | 2000 | 50% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.55B | 342M | 2,208% |
| Annual Yield % from dividends | 4.53 | 4.91 | 92% |
| Returns for 1 year | 6.74 | 7.90 | 85% |
| Returns for 3 years | 35.88 | 38.04 | 94% |
| Returns for 5 years | 8.21 | 11.08 | 74% |
| Returns for 10 years | 34.80 | 44.25 | 79% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement